清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Obesity and heart failure prognosis: paradox or reverse epidemiology?

医学 弗雷明翰心脏研究 心脏病学 心力衰竭 内科学 超重 肥胖悖论 肥胖 流行病学 冠状动脉疾病 风险因素 体质指数 人口 弗雷明翰风险评分 疾病 环境卫生
作者
Carl J. Lavie,Mandeep R. Mehra,Richard V. Milani
出处
期刊:European Heart Journal [Oxford University Press]
卷期号:26 (1): 5-7 被引量:128
标识
DOI:10.1093/eurheartj/ehi055
摘要

This editorial refers to ‘Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function’† by F. Gustafsson et al., on page 58 Obesity is a problem reaching epidemic proportions in westernized society and is a major cause of preventable death.1 Obesity has many adverse effects on coronary artery disease (CAD) risk factors and is probably an independent risk factor for CAD events. Epidemiological studies have clearly shown a strong relationship between obesity and increased risk of cardiovascular disease and mortality in the general population,1,2 although in some of these studies a ‘J-shaped’ or ‘U-shaped’ curve has been present, meaning that those individuals with low body mass index (BMI) also have increased mortality. Obesity is also known to exert numerous adverse effects on cardiac function. In early obesity, an expanded intravascular volume results in an increase in cardiopulmonary volume or increased pre-load.1,3 Over time these changes lead to an increased prevalence of eccentric left ventricular hypertrophy and the propensity for more complex ventricular dysrhythmias; we and others have noted these early abnormalities as well as improvements in both diastolic and systolic ventricular function following marked, purposeful weight reduction.1 Finding the relationship between obesity and heart failure (HF), however, has been complex. A recent epidemiological study from the Framingham Heart Study clearly indicates that obesity and being overweight are potent predictors of subsequent clinical HF.4 Although obesity causes abnormalities in diastolic and systolic function and predisposes to clinical HF, obese patients with HF paradoxically seem to have a more favourable clinical prognosis.1–3,5,6 Kalantar-Zadeh et al.2 have recently reviewed six studies demonstrating that, among patients with HF, obesity appears to be associated with a better overall clinical prognosis and patients with more severe HF tend to have lower BMI than do age- and gender-matched control subjects. Among the studies reviewed, Horwich et al.5 studied 1203 individuals with mostly class IV HF, and found that a higher BMI was associated with a better survival rate (Figure 1) and, in multivariate analysis, there was an inverse association between BMI and mortality. We recently studied 209 patients with mostly class II and III HF and a mean ejection fraction of only 23%; we found that higher BMI and higher percentage body fat were associated with better event-free survival during a 2 year follow-up.6 In fact, in multivariate analysis, a higher percentage body fat was the strongest independent predictor of event-free survival. We have described this as an ‘obesity paradox’ whereas others have described the relationship between some of the cardiovascular risk factors and chronic HF prognosis as ‘reverse epidemiology’.2 Importantly, only limited information is available on whether this relationship is causal or merely an association. It is postulated that lower body weight may be associated with a heightened catabolic state, which is associated with high levels of tumour necrosis factor and other cytokines and increased cortisol/dihydroepiandrosterone balance.6 Clearly, in advanced HF, cachexia and wasting appear to be independent predictors of increased mortality.7 However, in our cohort of patients with HF in the lowest quintile of body composition parameters, the BMI and percentage body fat values were at levels generally considered to be ‘healthy’ and certainly not at levels consistent with a cachetic state. In the current issue of the European Heart Journal, Gustafsson et al.8 present data which further suggest a protective influence of increasing BMI on subsequent mortality in 4700 patients hospitalized with HF. Moreover, they demonstrated the impact of chronic obstructive lung disease in these patients, and that obesity seems to be particularly protective in HF patients with more preserved systolic function. Unlike most of the other studies in the literature, however, they did not find a better clinical prognosis in obese patients with more systolic dysfunction, although they did note the considerable differences in their study population compared with the others in the literature, particularly the higher age and their acute hospitalization status. The strength of their study is the very large sample size and the hard endpoint (total mortality). A weakness is that their data may be confounded by presentation with an acutely decompensated HF event requiring hospitalization. There could also be an interaction of co-morbidities in that the patients who died were older and had more renal dysfunction, atrial fibrillation, smoking, and obstructive lung disease, and lower use of angiotensin converting enzyme inhibitors, and many of these factors, including lung disease, are known to be associated with a poor HF prognosis.9 In addition, medications were not accounted for and there was no description of detailed demographic profiles and co-morbidities in the two distinct HF cohorts with either preserved or reduced systolic function. Finally, their study assessed total mortality but not cardiac events or cause of death, and certainly obesity or body fat status could effect survival from non-cardiac causes. However, despite these potential study limitations, the constellation of findings by Gustafsson et al.8 support the general idea of an ‘obesity paradox’. The reasons for this apparent obesity paradox are uncertain. Several studies have suggested that the natriuretic peptide system and adiposity are closely linked; we recently demonstrated a reduced natriuretic peptide level in obese patients with HF.3 This lends credence to the explanation that the earlier expression of HF in the presence of obesity could be related to reduced circulating natriuretic peptides. Therefore, obese HF patients may present earlier due to symptoms at a less severe level of HF, therefore promoting discordance between symptoms and prognosis. It is also well recognized that peak oxygen consumption with exercise is a potent predictor of prognosis in advanced HF1 and, for practical purposes, fat does not consume oxygen or receive substantial perfusion. We have demonstrated that lean adjusted exercise indices (including peak oxygen consumption, anaerobic threshold, and oxygen pulse) all predict prognosis better than non-fat-adjusted variables, which may be particularly applicable to the favourable prognosis in HF patients with a high percentage body fat who generally have relatively high lean-adjusted exercise indices.10,11 In addition, most of the above HF studies, including the paper by Gustafsson et al.,8 have not accounted for the effects of non-purposeful weight loss, which may be associated with more advanced HF and a poor prognosis.1,7 Clearly, purposeful weight loss in HF patients with morbid obesity has been associated with improvements in systolic and diastolic function and HF classification,1 but no large studies have determined the impact of purposeful weight reduction on HF prognosis and mortality in either patients with preserved or abnormal systolic function. Finally, other lines of evidence have suggested enhanced protection with obesity against endotoxin/inflammatory cytokines as well as increased nutritional and metabolic reserve.3 Certainly, obesity could be associated with a better prognosis in HF and this relationship is not necessarily causal. In this regard, obesity is also associated with better prognosis in other distinct populations, including end-stage renal disease patients undergoing dialysis and the elderly,2 as well as patients with advanced cancers. Likewise, other conventional cardiovascular risk factors in addition to obesity, including high total cholesterol and higher blood pressure, are associated with better prognosis in chronic HF—hence, the term ‘reverse epidemiology’.2 Further studies are needed to elucidate the mechanism for this relationship between obesity and improved HF prognosis further. In addition, studies on modalities to improve nutritional/metabolic reserve and purposeful weight reduction, especially in obesity, on HF prognosis are urgently needed. doi:10.1093/eurheartj/ehi022 Figure 1 Risk-adjusted survival curves for the four BMI categories at 5 years in a study of 1203 individuals with moderate–severe HF. Survival was significantly better for the overweight and obese categories (from Horwich et al.,5 with permission).

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
真实的画板完成签到 ,获得积分10
刚刚
老北京完成签到,获得积分10
6秒前
逍遥子完成签到,获得积分10
8秒前
温暖奎完成签到,获得积分10
8秒前
10秒前
淡然完成签到 ,获得积分10
12秒前
seeyou14发布了新的文献求助20
14秒前
简奥斯汀完成签到 ,获得积分10
18秒前
miaorunquan完成签到,获得积分0
19秒前
半月完成签到 ,获得积分10
19秒前
zyjsunye完成签到 ,获得积分10
22秒前
健康的忘幽完成签到,获得积分10
27秒前
31秒前
闪闪小凡完成签到,获得积分10
35秒前
小小菜完成签到 ,获得积分10
36秒前
白的肥发布了新的文献求助10
39秒前
Alice完成签到 ,获得积分10
50秒前
n01W97的应助被科研通管家采纳,获得20
52秒前
詹姆斯哈登完成签到,获得积分0
56秒前
stone完成签到 ,获得积分10
1分钟前
我很好完成签到 ,获得积分10
1分钟前
清爽水之完成签到,获得积分10
1分钟前
tianshanfeihe完成签到 ,获得积分10
1分钟前
FashionBoy的应助被白的肥采纳,获得10
1分钟前
从容棉花糖完成签到,获得积分10
1分钟前
1分钟前
elsa622完成签到 ,获得积分10
1分钟前
1分钟前
白的肥发布了新的文献求助10
1分钟前
负责谷秋完成签到 ,获得积分10
1分钟前
白的肥完成签到,获得积分10
1分钟前
孤独剑完成签到 ,获得积分10
1分钟前
timesever完成签到,获得积分10
2分钟前
小新小新完成签到 ,获得积分10
2分钟前
amiee发布了新的文献求助10
2分钟前
义气绍辉完成签到,获得积分10
2分钟前
kylin完成签到 ,获得积分10
2分钟前
沉静的愫完成签到,获得积分10
2分钟前
李爱国的应助被段宏涛采纳,获得10
2分钟前
放手一搏完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185496
求助须知:如何正确求助?哪些是违规求助? 9574168
关于积分的说明 21834498
捐赠科研通 7783092
什么是DOI,文献DOI怎么找? 3434577
关于科研通互助平台的介绍 2558949
邀请新用户注册赠送积分活动 2481346